• BIVDA members area

Members' Press Releases

From the monthly archives: May, 2014

We are pleased to present below all posts archived in 'May, 2014'. If you still can't find what you are looking for, try using the search box.

Preliminary results for the year ended 31st December, 2013

Highlights

  • Revenue increased 86% to £2.14m (2012: £1.15m)
  • Licences / Sales / Services revenue up 137% to £1.92m (2012: £0.81m)
  • TMT® reagent sales rose 63% in 2013
  • Loss after tax reduced 26% to £3.15m (2012: £4.25m)
  • Cash at year-end £0.60m (2012: £0.86m). Placing of 3.57m shares in February 2014 raised £5m 
  • Significant benefits from the launch of TMT® 10-plex
  • Strategic $2.1m licence and research agreement with Thermo Fisher Scientific
  • Sharp growth in biomarker assays assisted by SysQuant® workflows
  • 17 patents granted , further 32 applications filed
  • Our Alzheimer’s disease research endorsed by David Cameron in Keynote G8 Summit speech

Read the rest of entry »

Studies Validate EKF Diagnostics’ Early Stage Test for Progressive Diabetic Kidney Disease

Independent scientific evidence confirms novel sTNFR1/2 biomarkers can accurately predict end-stage renal disease, up to 10 years in advance

Cardiff, UK – 22nd May 2014 – EKF Diagnostics, the global diagnostics company, today confirms the growing weight of independent scientific evidence as validation that soluble TNF Receptors 1 and 2 are strong biomarkers of progressive Diabetic Kidney Disease (DKD).

Read the rest of entry »

Archive